Localisation of somatostatin and somatostatin receptors in benign and malignant ovarian tumours
Open Access
- 25 June 2002
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 87 (1) , 86-90
Abstract
Somatostatin has been identified as having anti-proliferative, anti-angiogenic and pro-apoptotic actions in many tumour systems, and these effects are mediated through a family of five transmembrane G-protein coupled SRIF receptors. Ovarian cancer is the commonest gynaecological malignancy in the UK and maintenance therapy is urgently required. Native somatostatin expression and its receptors sst1,2,3 and 5 were studied with immunohistochemistry in 63 malignant and 35 benign ovarian tumours of various histological types. Fifty-seven out of 63 (90%) of malignant and 26/35 (74%) benign tumours expressed somatostatin. Receptors sst1,2,3 and 5 were expressed variably in epithelial, vascular and stromal compartments for both benign and malignant tumours. Somatostatin was found to correlate significantly with stromal sst1 (P=0.008), epithelial sst1 (P2 (P=0.019), vascular sst2 (P=0.026), epithelial sst3 (P=0.026), stromal sst5 (P=0.013) and vascular sst5 (P=0.038). Increased expression of native somatostatin correlating with somatostatin receptors in malignant ovarian tumours raises the possibility that either synthetic somatostatin antagonists or receptor agonists may have therapeutic potential.Keywords
This publication has 30 references indexed in Scilit:
- Somatostatin and Its Receptor FamilyFrontiers in Neuroendocrinology, 1999
- Macrophages and Microvessel Density in Tumors of the OvaryGynecologic Oncology, 1999
- Development of selective antibodies against the human somatostatin receptor subtypes sst1–sst5Molecular Brain Research, 1997
- Somatostatin receptors and their subtypes in human tumors and in peritumoral vesselsMetabolism, 1996
- Somatostatin Inhibits PC Cl3 Thyroid Cell Proliferation through the Modulation of Phosphotyrosine Phosphatase ActivityJournal of Biological Chemistry, 1996
- Classification and nomenclature of somatostatin receptorsTrends in Pharmacological Sciences, 1995
- Stimulation of tyrosine phosphatase and inhibition of cell proliferation by somatostatin analogues: mediation by human somatostatin receptor subtypes SSTR1 and SSTR2.Proceedings of the National Academy of Sciences, 1994
- High density of somatostatin receptors in veins surrounding human cancer tissue: Role in tumor‐host interaction?International Journal of Cancer, 1994
- Stimulatory effects of insulin and insulin-like growth factor I on migration and tube formation by vascular endothelial cellsAtherosclerosis, 1992
- A somatostatin analogue inhibits chondrosarcoma and insulinoma tumour growthEuropean Journal of Endocrinology, 1985